Patents by Inventor Elliot Wilkinson

Elliot Wilkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATION
    Publication number: 20230062872
    Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
    Type: Application
    Filed: February 9, 2022
    Publication date: March 2, 2023
    Inventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson
  • Pharmaceutical formulation
    Patent number: 11278506
    Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: March 22, 2022
    Assignee: RB HEALTH (US) LLC
    Inventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson
  • PHARMACEUTICAL FORMULATION
    Publication number: 20170100355
    Abstract: A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
    Type: Application
    Filed: October 11, 2016
    Publication date: April 13, 2017
    Inventors: Raghu Cavatur, Kevin Chen, Matthew Kaser, Hongchun Qiu, Ernest Joseph Woodhouse, Josef Borovicka, Elliot Wilkinson